Prozkoumejte nejčtenější články a videa na Campus Sanofi
We are pleased to share this extract from our recent webinar on ‘New perspectives in the treatment of pediatrics patients with severe Atopic Dermatitis and adult patients with severe prurigo nodularis’ with you. Watch Prof. Christian Vestergaard as he gives an insightful view on Disease modification in young children with AD.
We are pleased to share this extract from our recent webinar on ‘New perspectives in the treatment of pediatrics patients with severe Atopic Dermatitis and adult patients with severe prurigo nodularis’ with you. Watch Prof. Martin Metz as he discusses about Diagnosis of Prurigo Nodularis (PN).
We are pleased to share this extract from our recent webinar on ‘New perspectives in the treatment of pediatrics patients with severe Atopic Dermatitis and adult patients with severe prurigo nodularis’ with you. Watch Prof. Christian Vestergaard as he offers a deep dive into Biologics and their Mode of Action pediatric AD.
Beneficios de dupilumab en el tratamiento de EPOC moderada a grave con inflamación Tipo 2.
Descubra cómo el programa de diagnóstico EDL de Sanofi revoluciona la identificación de enfermedades raras como Pompe, Fabry y Gaucher. Con herramientas avanzadas y soporte especializado, agiliza el diagnóstico y la toma de decisiones clínicas.
Consulte las actualizaciones y novedades de la aplicación EDL Diagnóstico. ¡Disponible para PC y dispositivos móviles!
CD8+ T cell exhaustion rate predicts progression of T1D
GRS helps to select individuals at high risk for T1D for screening
Explore the association of GWAS and GRS and how they can improve T1D
People identified early through screening programs have milder disease and better quality of life compared to control